Evidence map›Paper›PMID 42003011›Full record

ArticleVirulence2026

Impact of antiviral treatment and initiation time on mother-to-child transmission in pregnant women with extremely high HBV DNA loads.

Wei Yi, Weihua Cao, Gang Wan, Shiyu Wang, Wen Deng, Ziyu Zhang, Xinxin Li, Yao Xie, Minghui Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei YiDepartment of Gynecology and Obstetrics, Beijing Ditan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-4241-8205
Weihua CaoDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Gang WanDepartment of Medical and Biological Statistics, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Shiyu WangDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Wen DengDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Ziyu ZhangDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Xinxin LiDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yao XieDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-4108-7037
Minghui LiDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To further reduce mother-to-child transmission (MTCT), this study aims to explore the factors influencing MTCT rate in pregnant women with extremely high HBV DNA loads (HBV DNA ≥ 1 × 10

Indexed as

Antiviral AgentsDNA, ViralHepatitis B, ChronicHepatitis B virusInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousViral LoadAdultFemaleHepatitis B VaccinesHumansImmunoglobulinsInfant, NewbornPregnancyRetrospective StudiesAntiviral AgentsDNA, Viralhepatitis B hyperimmune globulinHepatitis B VaccinesImmunoglobulinsantiviral therapychronic HBV infectionHBV DNA loadMother-to-child transmission

Identifiers

PMID42003011
PMCPMC13097786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.